Skip to main content

Table 4 Retention on ART 27 by gender, age and level of HIV clinics

From: Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling

  

Reference treatment centre

HIV management unit

Total

n/N

%

n/N

%

n/N

%

Gender

Male

284/558

50.9%

334/525

63.6%

618/1081

57.2%

Female

641/1148

55.8%

764/1118

68.3%

1405/2266

62.0%

Age range

Less than 4 years

13/25

52.0%

28/40

70.0%

41/65

63.1%

59 years

8/19

42.1%

9/17

52.9%

17/36

47.2%

1014 years

7/17

41.2%

15/18

83.3%

22/35

62.9%

1519 years

12/20

60.0%

15/30

50.0%

27/50

54.0%

2024 years

66/127

52.0%

74/108

68.5%

140/235

59.6%

2529 years

134/260

51.5%

168/233

72.1%

302/493

61.3%

3034 years

169/312

54.2%

182/294

61.9%

351/606

57.9%

3539 years

134/240

55.8%

187/280

66.8%

321/520

61.7%

4044 years

126/234

53.8%

158/230

68.7%

284/464

61.2%

4549 years

84/157

53.5%

97/149

65.1%

181/306

59.2%

5054 years

71/119

59.7%

64/102

62.7%

135/221

61.1%

55 years and

53/107

49.5%

88/118

74.6%

141/225

62.7%

Age range

Children

28/61

45.9%

52/75

69.3%

69.3%

58.8%

Adults

849/1575

53.9%

1033/1544

66.9%

1882/3119

60.3%

Total

Total

925/1706

54.2%

1098/1643

66.8%

2023/3349

60.4%

  1. Legend. n: frequency; %: proportion of patients in care for each region and in the total study population; Reference treatment centre provides mentorship to HIV management units within his health area. In bold are the most prevalent data on retention on ART according to gender and to age range